hhs a+1 l-carnitine lepidium 30 capsule A1 FORM CAPSUL hhs a1 l-carnitine lepidium review
Description
The different mutations in SLC22A5 probably give rise to differences in severity/onset of the disease
The efficacy of ALCAR in the prevention and treatment of chemotherapy-induced peripheral neuropathy remains to be established (94)
[DOI] [PubMed] [Google Scholar] Bonomini M., Di Liberato L., Zammit V., Arduini A
SF-36HS, SF-36 Health Survey
